CoreCap Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.6K Buy
2,420
+19
+0.8% +$439 ﹤0.01% 1333
2026
Q1
$57.5K Hold
2,401
﹤0.01% 1238
2025
Q4
$54.3K Hold
2,401
﹤0.01% 1293
2025
Q3
$48.4K Hold
2,401
﹤0.01% 1337
2025
Q2
$34.3K Sell
2,401
-23
-0.9% -$269 ﹤0.01% 1400
2025
Q1
$25.5K Buy
2,424
+23
+1% +$260 ﹤0.01% 1441
2024
Q4
$29.1K Buy
+2,401
New +$31.4K ﹤0.01% 1404
2024
Q2
Sell
-115
Closed -$1.87K 1879
2024
Q1
$1.87K Buy
+115
New +$1.8K ﹤0.01% 2136
2022
Q4
$1.41K Buy
+115
New +$1.43K ﹤0.01% 2003
2022
Q3
Sell
-115
Closed -$2K 963
2022
Q2
$2K Buy
+115
New +$2.72K ﹤0.01% 1854
2022
Q1
Sell
-147
Closed -$4K 972
2021
Q4
$4K Buy
+147
New +$4.57K ﹤0.01% 1790

Other funds holding ELAN

CoreCap Advisors's ELAN Position: Q2 2026 in Review

CoreCap Advisors increased its Elanco Animal Health (ELAN) stake by 0.79% in Q2 2026, buying an estimated $439 and bringing the position to 2,420 shares worth $59.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

CoreCap Advisors first reported a position in ELAN in Q4 2021 and has held it in 11 quarters since. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • CoreCap Advisors held 2,420 shares of Elanco Animal Health worth $59.6K as of Q2 2026.
  • CoreCap Advisors bought 19 Elanco Animal Health shares in Q2 2026, an estimated $439.
  • Elanco Animal Health made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1333 holding.
  • CoreCap Advisors first reported a position in Elanco Animal Health in Q4 2021 and has held it in 11 quarters since.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.